Arriving in the arena of excess body fat therapy, retatrutide is a unique approach. Unlike many existing medications, retatrutide works as a twin agonist, at once affecting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. This simultaneous activation promotes several advantageous effects, such as en